The global adherence packaging market is anticipated to accumulate a market value of US$ 988 million in 2023 and is expected to garner a valuation of US$ 1,870 million by exhibiting a CAGR of 6.59 % in the forecast period 2023 to 2033. The market for adherence packaging reflected growth with a 5 % CAGR in the historical period 2018 to 2022.
The poor adherence to pharmacological therapy and illness management has been linked to emergency hospitalization in individuals with chronic obstructive pulmonary disease. Owing to these factors, adherence packaging is one of the growing needs for such patients and is expected to witness significant growth in the forthcoming period.
The increasing efforts to reduce drug wastage is also driving the growth of the market. Medication waste has a substantial financial impact on the healthcare system and creates negative environmental consequences. Hence, the necessity to decrease medicine wastage becomes more important which opens up new avenues for the market expansion.
Along with this, rising government initiatives to increase the awareness to enhance the medicine intake regime of patients is further driving the market growth. Also, the surge in demand for packaging type that enable patient to keep a tab on their medicine intake is again fuelling the product sales.
On the other hand, advent of blister packaging that prevents contamination of compact medical devices and medicines from oxygen moisture and odor is anticipated to bring lucrative opportunities for market expansion. The blister packs and dosage strips with pills organized by time or date of day can easily simplify the management of medication routines. Increasing healthcare expenditure to enhance patient care is further expected to propel market growth. Similarly, introduction of smart features in the medication adherence packaging types is another key driving factor.
On the regional end, North America dominated the market in 2022 and is expected to retain its dominance by accumulating 38% market share by end of the forecast period. Factors such as the growing prevalence of chronic diseases, rapid growth of aging population, increasing healthcare expenditure, flourishing pharmaceuticals industry, high rate of medication non-adherence and rise in funding by government agencies are augmenting market growth in the region.
Likewise, Europe is expected to reflect fastest CAGR 6.1% during the projected period. The growth in this region is primarily driven by the availability of significant government funding for research and development, rising prevalence of cardiovascular diseases, strong presence of leading adherence packaging companies, and increasing ageing populace.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | US$ 988 million |
| Projected Market Value in 2033 | US$ 1,870 million |
| Growth Rate (2023 to 2033) | 6.59 % CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Recent developments and breakthroughs in technology, mergers, acquisitions, tie-ups, and partnerships within the companies involved in manufacturing adherence packaging solutions are expected to create lucrative opportunities for market growth during the forecast period.
The packaging for medical adherence includes the labeling and packaging of prescription products in such a way that the patient can take the drugs as instructed by the physician.
The adherence packaging for the drug is labelled with instructions, intensity and passing time by ensuring delivery to the correct patient. Due to adherence packaging remarkable staying power, blister packaging or blister cards for the medication is common, thus helping to encourage adherence to the medication in various ways that rely on the blister card design.
In general, the nursing homes offer inpatients the blister pack medicine with adherence packaging. When the blister pack is taken at home, it gives many of the same benefits, and the drugs prefer the blister packs with adherence packaging.
Some factors driving market growth include the rise in need to reduce the waste of medicines and the high rate of adherence packaging to medicines.
Principal Consultant
Medicines are the key methods used to prevent and treat chronic disease effectively; but, given their value and documented benefit, proper use of medicines remains a problem for both patients and providers alike. Patients also do not adhere to necessary drugs, leading to poor clinical results, higher medical costs and adverse effects on efficiency in the workplace and overall public health.
Proper scheduling of drugs for patients decreases the risk of being over- or under-medicated. Patients will have the medications packed for homebound customers and delivered to their door.
Adherence packaging in pharmacies can also opt to provide a card for the patient to take to their medical practitioners, which includes a full list of medications, their strengths, and the required dosing instructions to provide all prescribing physicians a thorough summary of the patient's clinical regimen. Both of those adherence-related benefits are projected to fuel demand growth over the forecast period.
The retail pharmacies are currently focused on the possible effect on their day-to-day operation, expense, software interface design, how staff should be educated, and state and federal guidance.
Through using adherence packaging systems for oral-solid drugs, pharmacies will also maximize their productivity, as research can be prepared for days with higher monthly refill levels, and consistency is greatly improved, as the entire adherence packaging process uses barcoding, standardized trays, and even barcoding for medical-to-bed services in hospital outpatient pharmacies or clinics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The direct costs of health care associated with non-adherence packaging in the United States is very much costly. Hyperlipidemia, hypertension, and/or type 2 diabetes had all been identified for the individuals examined in STOMPP (Study to Assess the Effect of Pharmacists and Pharmacy Facilities on Drug Non-Adherence). Most participants had a body mass index of more than 30, took around 10 medicines and had uncontrolled HbA1c diabetes of more than 7%.
The research also analyzed measures of clinical performance, quality of life, and data on costs and use. Similarly, according to the 2018 article titled "Medication Adherence: The Elephant in the House," adherence packaging can account for up to 50% of care delays, approximately 125,000 deaths and up to 25% of hospitalizations in the United States per year. The area is thus seeing an increase in demand for adherence packaging.
Explore Packaging Insights
View Reports
Adherence Packaging Market
